163 related articles for article (PubMed ID: 34804821)
1. ISPRF: a machine learning model to predict the immune subtype of kidney cancer samples by four genes.
Wang Z; Chen Z; Zhao H; Lin H; Wang J; Wang N; Li X; Ding D
Transl Androl Urol; 2021 Oct; 10(10):3773-3786. PubMed ID: 34804821
[TBL] [Abstract][Full Text] [Related]
2. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.
Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
Front Immunol; 2021; 12():749459. PubMed ID: 34603338
[TBL] [Abstract][Full Text] [Related]
3. Identification of molecular subtypes and diagnostic model in clear cell renal cell carcinoma based on collagen-related genes may predict the response of immunotherapy.
Hong Y; Lv Z; Xing Z; Xu H; Chand H; Wang J; Li Y
Front Pharmacol; 2024; 15():1325447. PubMed ID: 38375034
[No Abstract] [Full Text] [Related]
4. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
6.
Klümper N; Ralser DJ; Zarbl R; Schlack K; Schrader AJ; Rehlinghaus M; Hoffmann MJ; Niegisch G; Uhlig A; Trojan L; Steinestel J; Steinestel K; Wirtz RM; Sikic D; Eckstein M; Kristiansen G; Toma M; Hölzel M; Ritter M; Strieth S; Ellinger J; Dietrich D
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446578
[TBL] [Abstract][Full Text] [Related]
7. Identification of AKI signatures and classification patterns in ccRCC based on machine learning.
Wang L; Peng F; Li ZH; Deng YF; Ruan MN; Mao ZG; Li L
Front Med (Lausanne); 2023; 10():1195678. PubMed ID: 37293297
[TBL] [Abstract][Full Text] [Related]
8. Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma.
Lv D; Wu X; Wang M; Chen W; Yang S; Liu Y; Zeng G; Gu D
Front Cell Dev Biol; 2021; 9():621618. PubMed ID: 33796525
[TBL] [Abstract][Full Text] [Related]
9. Identification of
Yang H; Wang Y; Zhang Z; Li H
Front Genet; 2020; 11():905. PubMed ID: 32973873
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal Carcinoma Subtype Discovery via Immune Cell Scores from Tumor Microenvironment.
Sun Y; Liu Y; Chu H
J Immunol Res; 2023; 2023():2242577. PubMed ID: 37274867
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a classifier based on hub aging-related genes and aging subtypes correlation with immune microenvironment for periodontitis.
Peng L; Chen H; Wang Z; He Y; Zhang X
Front Immunol; 2022; 13():1042484. PubMed ID: 36389665
[TBL] [Abstract][Full Text] [Related]
13. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
16. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
17. Identification of subtype specific biomarkers of clear cell renal cell carcinoma using random forest and greedy algorithm.
Wu Y; Han W; Xu D; Wang X; Yang J; Lu Z; Chen X; Ding Y
Biosystems; 2021 Jun; 204():104372. PubMed ID: 33582210
[TBL] [Abstract][Full Text] [Related]
18. Identification of immune microenvironment subtypes and signature genes for Alzheimer's disease diagnosis and risk prediction based on explainable machine learning.
Lai Y; Lin P; Lin F; Chen M; Lin C; Lin X; Wu L; Zheng M; Chen J
Front Immunol; 2022; 13():1046410. PubMed ID: 36569892
[TBL] [Abstract][Full Text] [Related]
19. Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Zheng Y; Wen Y; Cao H; Gu Y; Yan L; Wang Y; Wang L; Zhang L; Shao F
Onco Targets Ther; 2021; 14():2085-2100. PubMed ID: 33790572
[TBL] [Abstract][Full Text] [Related]
20. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis.
Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X
Front Physiol; 2018; 9():399. PubMed ID: 29720944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
